186 results on '"Sarker, Shah-Jalal"'
Search Results
2. Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study
3. Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors
4. A phase II study of carboplatin AUC-10 guided by positron emission tomography–defined metabolic response in metastatic seminoma
5. Is abdominal drainage after open emergency appendectomy for complicated appendicitis beneficial or waste of money? A single centre retrospective cohort study
6. 1463: NG11-2 Phase Ib trial to reduce radiation-induced oral mucositis on patients with head & neck cancer
7. Supplementary Appendix 2 from Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test–Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
8. Supplementary Appendix 1 from Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test–Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
9. Durable graft‐versus‐leukaemia effects without donor lymphocyte infusions – results of a phase II study of sequential T‐replete allogeneic transplantation for high‐risk acute myeloid leukaemia and myelodysplasia
10. A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework
11. Accuracy of FAST scan in blunt abdominal trauma in a major London trauma centre
12. Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation
13. Cross-sectional exploration of the impact of the Dr Bawa-Garba case on doctors’ professional behaviours and attitudes towards the regulator
14. Measuring quality of life in people living with and beyond cancer in the UK
15. The RCSʼ Core Laparoscopic Skills Course is very effective: evidence based on objective assessments
16. Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors
17. Fertility and sexual function in long-term survivors of haematological malignancy: using patient-reported outcome measures to assess a neglected area of need in the late effects clinic
18. Uncovering trends in training progression for a national cohort of psychiatry trainees: discrete-time survival analysis
19. What Is the Best Option for Treating Venous Leg Ulcer Infection? Is It Systemic or Local Antimicrobials or a Combination of Both? A Retrospective Cohort Study
20. Comparison of 2 Extended Activities of Daily Living Scales With the Barthel Index and Predictors of Their Outcomes: Cohort Study Within the South London Stroke Register (SLSR)
21. Comparison of the therapeutic efficacy of 0.1% olopatadine hydrochloride and 0.025% ketotifen fumarate in allergic conjunctivitis
22. Individual care plans can reduce hospital admission rate for patients who frequently attend the emergency department
23. Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy
24. Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
25. THE USE OF EXTENDED CRITERIA DONORS: A SINGLE CENTRE EXPERIENCE: P-719
26. Incidence of Hemorrhagic Stroke in Black Caribbean, Black African, and White Populations: The South London Stroke Register, 1995–2004
27. Impact of the new UK licensing law on emergency hospital attendances: a cohort study
28. Can Waterlow score predict 30-day mortality and length of stay in acutely admitted medical patients (aged ≥65 years)? Evidence from a single centre prospective cohort study
29. Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer
30. A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
31. AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.
32. Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia
33. A study of vistusertib in combination with selumetinib in patients with advanced cancers: TORCMEK phase Ib results.
34. Patient-specific prediction of functional recovery after stroke
35. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function
36. Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2–Positive Metastatic Bladder Cancer
37. The relationships of age and length of service with job satisfaction: an examination of hotel employees in Thailand
38. Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma
39. Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors
40. Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
41. Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor–Positive Breast Cancer
42. Carboplatin AUC 10 in metastatic seminoma: Role of early PET scanning to reduce the amount of treatment while maintaining outcome—A phase 2 study (CarPET).
43. ARB: Phase II window of opportunity study of short-term preoperative treatment with enzalutamide in ER-positive and triple-negative breast cancer.
44. A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
45. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis
46. A phase II/III, double-blind, randomized trial comparing maintenance lapatinib versus placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer patients.
47. Addition of apatorsen, an inhibitor of Hsp27, to first-line gemcitabine/carboplatin in advanced squamous cell lung cancer: Design of the Cedar study.
48. Abstract S2-03: Preoperative window of opportunity study of the PI3K inhibitor pictilisib (GDC-0941) plus anastrozole vs anastrozole alone in patients with ER+, HER2-negative operable breast cancer (OPPORTUNE study)
49. A randomized phase II study of AZ2014 versus everolimus in patients with VEGF refractory metastatic clear cell renal cancer (mRCC).
50. Late Effects: An Evaluation of Contrasting Physical and Psychological Experiences Between Child and Adult Hodgkin Survivors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.